METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID
The invention provides a method of treating or preventing polycystic ovarian syndrome (PCOS) in a mammal, comprising administering chlorogenic acid in an amount effective to treat or prevent PCOS in the mammal. In an embodiment of the invention, the method further comprises administering L-cysteine to the mammal.
1 . A method of treating or preventing polycystic ovarian syndrome (PCOS) in a mammal, the method comprising administering chlorogenic acid in an amount effective to treat or prevent PCOS in the mammal.
2 . The method of claim 1 , wherein administering chlorogenic acid comprises administering a pharmaceutical composition comprising chlorogenic acid and a pharmaceutically acceptable carrier.
3 . The method of claim 2 , wherein the pharmaceutical composition is a solid pharmaceutical composition.
4 . The method of claim 2 , wherein the pharmaceutically acceptable carrier comprises one or more sweeteners.
5 . The method of claim 2 , wherein the pharmaceutically acceptable carrier comprises one or more flavorants.
6 . The method of claim 1 , comprising administering the chlorogenic acid orally.
7 . The method of claim 1 , comprising administering chlorogenic acid in a dose of about 0.2 g to about 1.5 g.
8 . The method of claim 1 , comprising administering chlorogenic acid in a dose of about 0.5 g to about 1.25 g.
9 . The method of claim 1 , comprising administering chlorogenic acid in a dose of about 1 g.
10 . The method of claim 1 , comprising administering a food and/or beverage comprising chlorogenic acid.
11 . The method of claim 1 , further comprising administering L-cysteine to the mammal.
12 . The method of claim 11 , comprising administering L-cysteine in a dose of about 250 mg to about 1500 mg.
13 . The method of claim 11 , comprising administering L-cysteine in a dose of about 500 mg to about 1200 mg.
14 . The method of claim 11 , comprising administering L-cysteine in a dose of about 600 mg.
15 . The method of claim 11 , wherein administering chlorogenic acid and L-cysteine comprises administering a pharmaceutical composition comprising chlorogenic acid, L-cysteine, and a pharmaceutically acceptable carrier.
16 . The method of claim 15 , comprising administering the pharmaceutical composition comprising chlorogenic acid, L-cysteine, and a pharmaceutically acceptable carrier orally.
17 . The method of claim 15 , wherein the pharmaceutical composition is a solid pharmaceutical composition.
18 . The method of claim 17 , wherein the pharmaceutical composition is in powder form.
19 . The method of claim 15 , wherein the pharmaceutically acceptable carrier comprises one or more sweeteners.
20 . The method of claim 15 , wherein the pharmaceutically acceptable carrier comprises one or more flavorants.
21 . The method of claim 11 , comprising administering a food and/or beverage comprising chlorogenic acid and L-cysteine.